Corcept Therapeutics Inc. (CORT)

NASDAQ

$121,28

$+0,02

(+0,02%)

After-Hours

Corcept Therapeutics Inc. (CORT) Live Price Chart

Last updated: ⁦2026-10-12 22:44:20⁩. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.

Summary

Corcept Therapeutics Inc. (CORT) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $121,28, with a market capitalisation of $13,10B and a P/E ratio of 240,42. Over the past 52 weeks, its price has ranged from $28,66 to $126,38. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$13,10B
Open	$121,24
Day's High	$126,38
Day's Low	$0,68
Previous Close	$121,19
Volume	394,06K
Average Volume	1,28M
P/E Ratio	240,42
52-Week High	$126,38
52-Week Low	$28,66
Dividend Yield	--
Earnings Date	--

Corcept Therapeutics Inc. (CORT) After-Hours Stock Price

Corcept Therapeutics Inc. (CORT) is trading at $121,19 in after-hours trading as of 2026-10-12 22:27:00, unchanged from the regular-session close of $121,19.

After-hours trading shows how investors are pricing CORT after the regular session closes. The current after-hours price is near the regular-session close, indicating neutral after-hours sentiment.

Corcept Therapeutics Inc. (CORT) 7-Day Stock Price Change

Over the past seven days, Corcept Therapeutics Inc. (CORT) moved from $114,03 to $121,28, representing a gain of 6,36% ($7,25).

The stock traded between $111,94 and $122,81 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.

The average daily volume was 770,05 thousand shares, down versus the previous seven-day period, indicating lower trading activity.

CORT 52-Week Price Position

Position in Range: 94,8%

52W Low$28,66

52W High$126,38

CORT is currently trading at $121,28, placing it 94,8% of the way from its 52-week low of $28,66 to its 52-week high of $126,38. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Corcept Therapeutics Inc. (CORT)?

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic, and neuropsychiatric disorders by modulating the effect of the cortisol hormone. The company markets Korlym (mifepristone) tablets and its authorized generic version, which is an oral medication for the treatment of hypercortisolism (also known as Cushing's syndrome). Additionally, its pipeline contains several key compounds, such as Relacorilant, Dazucorilant, Miricorilant, etc., that are being evaluated in clinical trials as potential treatments for a variety of serious disorders like hypercortisolism, solid tumors (including ovarian, endometrial, cervical, pancreatic, and prostate cancers), ALS, and MASH.

Corcept Therapeutics Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	730
Exchange	NASDAQ
Company Website	https://www.corcept.com

How to Buy Corcept Therapeutics Inc. (CORT) Stock on MEXC

Eligible investors can buy real shares of Corcept Therapeutics Inc. (CORT) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for CORT and Place Your Order

Open the RealStocks trading page and search for CORT. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Corcept Therapeutics Inc. (CORT) stock price today?

Corcept Therapeutics Inc. (CORT) is currently trading at $ 121,28, up 0,07% ($0,09) from the previous close of $ 121,19. Intraday prices update in real time during regular trading hours.

2.Is CORT stock going up or down today?

As of 2026-10-12 22:27:00, CORT is trading at $ 121,28, up 0,07% ($0,09) from its previous close of $ 121,19. The stock has traded between $ 0,68 and $ 126,38 during today’s regular session. Past price movements do not guarantee future results.

3.What is CORT pre-market price?

As of 2026-10-12 22:27:00, CORT is trading at $ 120,90 in pre-market trading, down 0,24% ($0,29) from the previous close of $ 121,19. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is CORT after-hours price?

As of 2026-10-12 22:27:00, CORT is trading at $ 121,19 in after-hours trading, unchanged from the regular-session close of $ 121,19. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is CORT stock trading now?

CORT trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does CORT sit relative to its 52-week high and low?

Over the past 52 weeks, CORT has traded between a low of $ 28,66 and a high of $ 126,38. At $ 121,28, the stock is positioned 94,8% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Corcept Therapeutics Inc. in?

Corcept Therapeutics Inc. (CORT) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Corcept Therapeutics Inc.'s market capitalisation and where is it listed?

Corcept Therapeutics Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 13,10B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is CORT valued in terms of P/E ratio and EPS?

CORT trades at a P/E ratio of 240,42, based on trailing-twelve-month EPS of $ 0,50. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Corcept Therapeutics Inc. pay a dividend?

Corcept Therapeutics Inc. pays an indicated annual cash dividend of $ 0,00 per share, with a current dividend yield of 0,00% based on the latest share price. Dividend policies are subject to change at the board's discretion.